Lopinavir Completed Phase 3 Trials for Plasmodium Infections / Human Immunodeficiency Virus (HIV) Infections Prevention

clinicaltrials.gov IdentifierTitleDrugs
NCT00993031Protease Inhibitors to Reduce Malaria Morbidity in HIV-Infected Pregnant Women
NCT00978068HIV Protease Inhibitors for the Prevention of Malaria in Ugandan Children
NCT01061151Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Resource-Limited Countries
NCT00164736Breastfeeding, Antiretroviral, and Nutrition Study
NCT00640263Comparison of Efficacy and Safety of Infant Peri-exposure Prophylaxis With Lopinavir/Ritonavir Versus Lamivudine to Prevent HIV-1 Transmission by Breastfeeding
NCT00086359Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIV
NCT00074581Preventing Sexual Transmission of HIV With Anti-HIV Drugs